Based on the present analysis of the comparability, completeness, validity and timeliness of premalignant lesions of vulva and vagina, we conclude that the Cancer Registry of Norway is able to monitor such premalignant lesions satisfactorily.
David Guerrero, Rosa Guarch, Amaya Ojer, Juan Manuel Casas Fernández de Tejerina, Carolina Méndez‐Meca, Manel Esteller, Edurne Barba‐Ramos, F. García-Bragado, A Puras
Discussion(0)
No comments yet. Be the first to comment.